Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

Real-world study of 20,368 cataract operations: do intraoperative sub-conjunctival steroids reduce rate of cystoid macular oedema (CMO) following cataract surgery?

Search Title by author or title

Session Details

Session Title: Cataract Surgery & Retinal Complications

Session Date/Time: Tuesday 25/09/2018 | 16:30-18:00

Paper Time: 16:30

Venue: Room A3, Podium 1

First Author: : M.Teo UK

Co Author(s): :    P. Ursell   R. Muniraju                 

Abstract Details


To assess if intra-operative subconjunctival (SC) steroids have an effect on rates of post-operative CMO in normal patients, and in diabetics with and without diabetic retinopathy.


This was a retrospective, single-centre, non-randomised observational case series studying 20,368 cataract surgeries collected via the electronic patient record at Epsom and St Helier Hospitals, London, UK from Oct 2007 to November 2017.


The rate of cystoid macular oedema (recorded within 3 months of cataract operation) and whether or not SC steroids were administered intra-operatively were analysed in patients with uncomplicated operations (no PC rupture, vitreous loss, choroidal haemorrhage, iris trauma). Patients were divided into 3 categories, (a) normal (non-diabetics), (b) diabetics without retinopathy or (c) with retinopathy.


There was no difference in incidence of raised IOP ( >21mmHg) between the groups who did and did not receive subconjunctival steriods (0.75% in both groups).


In this large study, intra-operative subconjunctival steroids appear to reduce rate of CMO in all categories, particularly high risk diabetic patients with known diabetic retinopathy.

Financial Disclosure:


Back to previous